Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant

NCT05814835 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT05814835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05814835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant
Lead sponsor
Chinese PLA General Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 7, 2022
Completion date
December 18, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant solid tumors